CN Stock MarketDetailed Quotes
300869 Contec Medical Systems
- 13.52
- -0.42-3.01%
Market Closed Jan 2 15:00 CST
5.43BMarket Cap-281.67P/E (TTM)
14.03High13.39Low39.48KlotVolume13.94Open13.94Pre Close54.32MTurnover1.57%Turnover Ratio32.74P/E (Static)401.80MShares20.0852wk High2.85P/B3.40BFloat Cap12.1252wk Low16.73Limit Up251.57MShs Float307.03Historical High11.15Limit Down4.59%Amplitude12.12Historical Low0.30Dividend TTM13.76Avg Price20.17KlotAsk2.22%Div YieldTTM100Lot Size18.33KlotBid
Contec Medical Systems Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -45.91%333.89M | -57.17%211.79M | -73.10%99.18M | 4.89%746.9M | 33.55%617.23M | 48.88%494.48M | 101.21%368.7M | -21.63%712.11M | -35.75%462.18M | -35.50%332.13M |
| Operating revenue | -45.91%333.89M | -57.17%211.79M | -73.10%99.18M | 4.89%746.9M | 33.55%617.23M | 48.88%494.48M | 101.21%368.7M | -21.63%712.11M | -35.75%462.18M | -35.50%332.13M |
| Other operating revenue | ---- | -9.36%1.98M | ---- | 23.90%4.25M | ---- | 25.99%2.18M | ---- | -11.27%3.43M | ---- | -12.81%1.73M |
| Total operating cost | -21.55%336.66M | -31.66%212.97M | -48.18%102.18M | 3.12%568.89M | 55.53%429.15M | 52.71%311.66M | 90.79%197.19M | 8.21%551.7M | -31.00%275.93M | -28.90%204.08M |
| Operating cost | -35.23%167.27M | -44.24%106.96M | -62.06%50.19M | -15.29%316.82M | 3.39%258.24M | 5.01%191.84M | 32.28%132.3M | -19.17%374.02M | -30.87%249.77M | -27.83%182.69M |
| Operating tax surcharges | -40.55%6.52M | -49.30%4.53M | -59.55%2.8M | 27.82%12.85M | 116.91%10.98M | 319.40%8.94M | 686.57%6.92M | 61.25%10.06M | 2.61%5.06M | -48.13%2.13M |
| Operating expense | -28.64%56.44M | -40.77%36.43M | -52.89%16.17M | 30.46%117.69M | 114.04%79.1M | 147.98%61.5M | 258.01%34.33M | 36.46%90.21M | -6.89%36.95M | -10.21%24.8M |
| Administration expense | -17.63%26.68M | -21.69%17.83M | -25.13%10.8M | 21.32%41.78M | 60.31%32.4M | 64.24%22.76M | 88.11%14.42M | 4.85%34.44M | -11.48%20.21M | 1.23%13.86M |
| Financial expense | 88.26%-3.68M | 64.50%-8.83M | 68.79%-4.93M | 38.64%-30.85M | 69.30%-31.35M | 58.99%-24.88M | 53.92%-15.78M | 59.50%-50.28M | -37.96%-102.13M | -49.94%-60.67M |
| -Interest expense (Financial expense) | ---- | ---- | ---- | 136.39%45.1M | ---- | ---- | ---- | 566.46%19.08M | ---- | ---- |
| -Interest Income (Financial expense) | ---- | ---- | ---- | 3.67%-81.18M | ---- | ---- | ---- | -25.68%-84.27M | ---- | ---- |
| Research and development | 4.54%83.43M | 8.85%56.06M | 8.54%27.14M | 18.60%110.6M | 20.79%79.81M | 24.77%51.5M | 28.52%25.01M | 41.16%93.25M | 46.12%66.07M | 42.71%41.27M |
| Credit Impairment Loss | -455.54%-1.19M | -387.57%-1.42M | -912.02%-670.64K | 152.76%1.08M | 118.03%333.74K | 72.44%-291.02K | 265.87%82.59K | -456.30%-2.05M | -633.89%-1.85M | -1,254.16%-1.06M |
| Asset Impairment Loss | -3.17%-8.76M | 16.31%-6.13M | 0.90%-3.19M | -569.24%-39.11M | -77.12%-8.49M | -124.23%-7.32M | -171.47%-3.22M | 45.41%-5.84M | -62.16%-4.8M | -49.18%-3.27M |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.04 | ---- |
| Other net revenue | -58.94%13.25M | -67.33%9.09M | -65.21%5.81M | -85.18%8.72M | 242.49%32.27M | 1,537.76%27.83M | 891.11%16.7M | 755.65%58.86M | -27.37%9.42M | -74.63%1.7M |
| Fair value change income | 101.97%916.58K | 103.32%1.55M | 102.50%562.92K | -95.66%2.02M | -644.60%-46.58M | ---46.63M | ---22.52M | --46.64M | --8.55M | --0 |
| Invest income | -73.10%15.36M | -80.21%11.1M | -71.86%7.7M | 44.10%11.47M | --57.11M | --56.07M | --27.35M | 402.85%7.96M | --0 | --0 |
| Asset deal income | 3,050.02%166.24K | 240.84%7.94K | ---28K | 73.90%-67.8K | ---5.64K | ---5.64K | ---- | -493.85%-259.79K | --0 | --0 |
| Other revenue | -77.41%6.76M | -84.68%3.98M | -90.41%1.44M | 168.42%33.33M | 297.91%29.9M | 331.91%26.01M | 413.61%15M | -24.35%12.42M | -47.60%7.52M | -24.14%6.02M |
| Operating profit | -95.25%10.47M | -96.25%7.91M | -98.51%2.81M | -14.84%186.73M | 12.60%220.34M | 62.36%210.65M | 130.73%188.21M | -45.96%219.28M | -41.12%195.68M | -44.69%129.75M |
| Add:Non operating Income | 218.34%1.38M | 819.40%1.18M | 1,346.02%598.03K | -1.45%476.33K | 62.58%432.28K | 4,240.21%128.5K | 8,408.73%41.36K | -81.62%483.35K | -89.82%265.88K | -99.88%2.96K |
| Less:Non operating expense | 13.85%690.12K | 16.72%583.37K | -7.97%286.45K | 197.36%1.08M | 159.23%606.17K | 191.94%499.82K | 759.89%311.25K | -4.47%364.73K | -30.84%233.84K | -32.89%171.21K |
| Total profit | -94.93%11.16M | -95.96%8.5M | -98.34%3.12M | -15.16%186.13M | 12.50%220.17M | 62.28%210.28M | 130.50%187.94M | -46.23%219.39M | -41.51%195.71M | -45.26%129.58M |
| Less:Income tax cost | -94.99%1.26M | -98.77%337.21K | -106.89%-1.23M | -12.21%20.36M | 16.50%25.05M | 92.88%27.39M | 117.39%17.88M | -58.32%23.19M | -53.81%21.5M | -58.53%14.2M |
| Net profit | -94.92%9.9M | -95.53%8.17M | -97.44%4.35M | -15.51%165.77M | 12.00%195.12M | 58.51%182.89M | 131.97%170.05M | -44.32%196.2M | -39.53%174.21M | -43.01%115.38M |
| Net profit from continuing operation | -94.92%9.9M | -95.53%8.17M | -97.44%4.35M | -15.51%165.77M | 12.00%195.12M | --182.89M | 131.97%170.05M | -44.32%196.2M | -39.53%174.21M | ---- |
| Net profit of parent company owners | -94.92%9.9M | -95.53%8.17M | -97.44%4.35M | -15.51%165.77M | 12.00%195.12M | 58.51%182.89M | 131.97%170.05M | -44.32%196.2M | -39.53%174.21M | -43.01%115.38M |
| Earning per share | ||||||||||
| Basic earning per share | -94.93%0.0246 | -95.65%0.02 | -97.45%0.0108 | -16.33%0.41 | 11.99%0.4856 | 58.62%0.46 | 131.89%0.4232 | -44.32%0.49 | -39.53%0.4336 | -42.00%0.29 |
| Diluted earning per share | ---- | ---- | --0 | -16.67%0.4 | 13.25%0.4625 | ---- | --0 | --0.48 | -43.04%0.4084 | ---- |
| Other composite income | -153.58%-713.85K | -95.14%78.99K | 75.83%-135.26K | -74.54%761.8K | -64.36%1.33M | -1.46%1.63M | 32.88%-559.57K | 544.19%2.99M | 4,614.06%3.74M | 1,071.10%1.65M |
| Other composite income of parent company owners | -153.58%-713.85K | -95.14%78.99K | 75.83%-135.26K | -74.54%761.8K | -64.36%1.33M | -1.46%1.63M | 32.88%-559.57K | 544.19%2.99M | 4,614.06%3.74M | 1,071.10%1.65M |
| Total composite income | -95.32%9.19M | -95.53%8.25M | -97.51%4.22M | -16.40%166.53M | 10.40%196.45M | 57.67%184.51M | 133.87%169.49M | -43.36%199.2M | -38.21%177.94M | -42.15%117.03M |
| Total composite income of parent company owners | -95.32%9.19M | -95.53%8.25M | -97.51%4.22M | -16.40%166.53M | 10.40%196.45M | 57.67%184.51M | 133.87%169.49M | -43.36%199.2M | -38.21%177.94M | -42.15%117.03M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
